MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH;UNIVERSITY OF WASHINGTON
发明人:
申请号：
EP08843542.5
公开号：
EP2215111B1
申请日:
2008.10.30
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present invention provides HLA-DR (MHC class II) binding peptides derived from the ovarian/breast cancer associated antigens, Human Epidermal Growth Factor Receptor 2 (HER-2/neu), Carcinoembryonic Antigen (CEA), Insulin Growth Factor Binding Protein 2 (IGFBP-2), and Cyclin D1. The immunogenic peptides can be used in cancer vaccines.
